The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples